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Abstract
Background—Unipolar major depressive disorder (MDD) is characterized by anomalous
neurobiological responses to pleasant stimuli, a pattern that may be linked to symptoms of
anhedonia. However, the potential for psychotherapy to normalize neurobiological responses to
pleasant stimuli has not been evaluated.
Methods—Twelve adults with and 15 adults without MDD participated in two identical
functional magnetic resonance imaging (fMRI) scans that utilized a Wheel of Fortune task.
Between scans, MDD outpatients received Behavioral Activation Therapy for Depression, a
psychotherapy modality designed to increase engagement with rewarding stimuli and reduce
avoidance behaviors.
Results—75% of adults with MDD were treatment responders, achieving post-treatment HAM-
D score of six or below. Relative to changes in brain function in the matched nondepressed group,
psychotherapy resulted in functional changes in structures that mediate responses to rewards,
including the paracingulate gyrus during reward selection, the right caudate nucleus (i.e., the
dorsal striatum), during reward anticipation, and the paracingulate and orbital frontal gyri during
reward feedback. There was no effect of diagnostic status or psychotherapy on in-scanner task-
related behavioral responses.
Conclusions—Behavioral Activation Therapy for Depression, a psychotherapy modality
designed to increase engagement with rewarding stimuli and reduce avoidance behaviors, results
*Address correspondence by dichter@med.unc.edu, or by mail to: Dr. Gabriel S. Dichter, Department of Psychiatry, University of





Biol Psychiatry. Author manuscript; available in PMC 2013 May 20.
Published in final edited form as:













in improved functioning of unique reward structures during different temporal phases of responses
to pleasurable stimuli, including the dorsal striatum during reward anticipation.
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Introduction
Neuroimaging research into the neurobiology of unipolar major depressive disorder (MDD)
has established a model of the pathophysiology of MDD that implicates impaired cortico-
limbic functioning in the onset and maintenance of depressive symptoms (1–4). The
majority of this research has focused on either (a) resting states data (5–7), or (b) the
processing of unpleasant stimuli (8–11). However, far less research has focused on
processing pleasant events, and thus the biological basis of anhedonia in MDD is less well
understood. Furthermore, the potential for change in regional neuroanatomical functioning
in response to pleasant events after antidepressant treatment has not bee evaluated.
Functional neuroimaging studies of responses to pleasant stimuli in MDD implicate the
striatum (12–14) as well as a host of other reward structures, including the medial prefrontal
cortex (15, 16), the pregenual and subgenual anterior cingulate, and the medial frontal gyrus
(17, 18). However, these studies have assessed responses to the presentation of pleasant
stimuli, whereas nonclinical neuroimaging studies have documented that certain reward
structures, and the striatum in particular, responds preferentially to anticipation of pleasant
stimuli (19–21).
To date, four studies of reward processing in MDD have investigated responses to different
temporal phases of reward processing. Forbes and colleagues (22) reported that children
with MDD demonstrated decreased orbitofrontal cortex, anterior cingulate, amygdala, and
caudate activation during both reward anticipation and feedback, but found little evidence of
differential effects contingent on the temporal phase of the response. Additionally, MDD
participants had a range of comorbid disorders. Forbes and colleagues (23) reported reduced
striatal activation in depressed adolescents during reward anticipation and reward outcome
that predicted positive affect in natural environments. Knutson and colleagues (24)
employed a monetary incentive delay task and found no striatal activation differences
between adult groups during reward anticipation, but increased anterior cingulate activation
during anticipation of monetary gains in MDD.
Finally, our own research group reported (25) anomalous neural responses during reward
selection, anticipation, and feedback in adults with MDD using a Wheel-of-Fortune task
(19). The MDD group was characterized by reduced striatal activation during reward
selection, anticipation, and feedback, by hyperresponsivity in orbitofrontal cortex during
reward selection, and by decreased activation of the middle frontal gyrus and the anterior
cingulate during reward selection and anticipation. This study demonstrated unique regions
of functional deficits in MDD during different temporal phases of reward processing, and,
most critically, that striatal dysfunction in MDD was evident during the anticipatory phase.
There is a growing neuroimaging literature evaluating response to antidepressant
interventions in MDD. Antidepressant medications increase glucose metabolism in the
dorsolateral, ventrolateral, and medial aspects of the prefrontal cortex and the anterior
cingulate cortex (26) as well as the striatum (27–30), the insular cortex (31), extrastriate
cortex (32), and the caudate nucleus and thalamus (33). Although less research has
examined functional neural responses after psychotherapy, available data suggest that
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psychotherapy predicts metabolic changes in the cingulate and frontal cortices (8, 34–37),
basal ganglia (38), and hippocampus (39). Furthermore, a consistent pattern has emerged
that antidepressant response is predicted by pretreatment functioning of the anterior
cingulate, shown in studies of response to sleep deprivation (40–43), psychopharmacologic
intervention (1, 26, 44–46), and cognitive behavioral therapy (34, 35). However, no study
has examined brain activation changes after antidepressant treatment (medication or
psychotherapy) using tasks sensitive to the chronometry of reward responses. This omission
is striking given that reward anticipation may represent the most valid method to assay
treatments that putatively improve anhedonia (47).
The present investigation evaluated the effects of Brief Behavioral Activation Treatment for
Depression (48) on brain activation using a Wheel of Fortune task that dissociates reward
choice selection, anticipation, and feedback. Because of linkages between animal models of
MDD, decreased reward seeking behaviors, and functioning of the striatum (49–51), we had
particular interest in psychotherapy-induced changes in striatal functioning during reward
anticipation. We hypothesized that psychotherapy would cause decreased depressive
symptoms accompanied by increased striatal functioning. We further hypothesized that
psychotherapy would impact the activity of regions shown to have aberrant functioning pre-
psychotherapy in a variety of studies, including the subgenual anterior cingulate cortex
during reward decision-making, the striatum during reward anticipation, and the middle
frontal gyrus and the orbitofrontal gyrus during reward feedback (24, 25).
Method
Participants
Inclusion/exclusion criteria and Time 1 fMRI results have been reported previously (25).
After a complete description of the study to participants, written informed consent was
obtained. Participants were paid $45 for each imaging session. Sixteen depressed (9
females) and 15 nondepressed (9 females) participants enrolled in the study. One depressed
female withdrew after her initial interview. Not included in the MRI analyses are the data
from one depressed female who had frank abnormalities in brain anatomy. Two depressed
participants did not return for psychotherapy sessions after the first imaging session. Thus,
the final sample was 12 depressed (6 females, average age 39.0 ± 10.4 years) and 15
nondepressed (9 females, average age 30.8 ± 9.6 years) participants. Groups did not differ in
age [MDD mean(SD)= 34.8(14.3) years, range = 23–53; nondepressed mean(SD)= 30.8
(9.7) years, range = 21–43], estimated verbal IQ (52) (MDD=112.8, nondepressed =117.7),
smoking status (all nondepressed participants were non-smokers, all but two depressed
participants were non-smokers), the number of days between scans [MDD mean(SD)=102.2
(15.4) days; nondepressed mean(SD)=102.5 (10.1) days], p’s > .05, or gender distribution,
χ2 (1) = .99 p >0.32, but differed in socioeconomic status (53) [MDD mean(SD)= 36.8
(12.0); nondepressed mean(SD)= 45.8 (2.4).
Brief Behavioral Activation Treatment for Depression (BATD)
MDD outpatients received an average of 11.4 (SD=2.0; range: 8–14) weekly sessions of
Brief Behavioral Activation Treatment for Depression (BATD). Additional sessions (up to a
total of 15 sessions; average of 1.4 per participant) were subsequently offered to help
participants consolidate therapeutic gains and transition to follow-up care, as necessary.
Early responders were given the option to end therapy after eight sessions and non-
responders received the maximum number of sessions before being referred for additional
treatment.
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BATD is a structured and validated psychotherapy method designed to increase engagement
with functional, potentially rewarding behaviors and reduce avoidance behaviors (48).
Patients are encouraged to expose themselves to reinforcing situations and to inhibit the
behavioral withdrawal often characteristic of MDD (54). Behavioral activation interventions
were recently shown to be as effective as Cognitive Behavioral Therapy or paroxetine in
reducing depressive symptoms in a large-scale clinical trial (55).
fMRI Task
The Wheel of Fortune (WOF) task is a computerized two-choice decision-making task
involving probabilistic monetary outcomes (see Figure 1). Participants were instructed that
they would take home up to $45 of the money they won ($40 minimum) and that they
should try to win as much money as possible. On each trial, participants first chose between
two options, each with an assigned probability of winning a certain amount of money. If
correct, the participant won the designated amount; if not, the participant won nothing.
Three conditions were used (56): selecting between (i) a 10% chance of winning $7 and a
90% chance of winning $ 1; (ii) a 30% chance of winning $2 and a 70% chance of winning
$1; and (iii) two 50% chances of winning $2. The task was originally designed so that all
possible options would be selected by most participants. Each of the three monetary
conditions was displayed as a two-slice wheel of fortune, with each slice representing a
distinct option. The area of the slice matched the likelihood of winning (e.g., 10%) an
explicit amount of money (e.g., $7). A control condition included all the sensory-motor
attributes of the monetary conditions, but lacked decision-making, anticipation of a gain, and
response to gain. This control condition consisted of a wheel of fortune, but this wheel was
of a single color (i.e., no slices).
During the “selection” phase, participants viewed one type of wheel and were asked to select
either the blue or the magenta slice by pressing the button corresponding to where the color
was located (i.e., right or left). During the “anticipation” phase, participants continued to
view the wheel while a six-point rating scale appeared on the screen to prompt them to rate
their level of confidence of winning (1=unsure, 6=sure). During the "feedback” phase,
participants were shown the dollar amount won ($0 if not won), the cumulative dollar
amount, and a six-point pictorial rating scale along which they rated how they felt
(1=neutral, 6=very happy, if a win trial; 1=very sad, 6=neutral if a loss trial). During the
control condition, participants made button responses in a random fashion during all phases
of the task. All responses were recorded on two four-key button-boxes, using three buttons
per hand. This version of the task is identical to that described in Ernst et al (2004), except
the anticipation and feedback phases included six, instead of five, behavioral response
options.
Participants completed four runs of 46 trials that lasted approximately 12 min each. Each
trial lasted between 10.5 – 14.5 s and was composed of three phases: selection (3 s),
anticipation (jittered between 3.5–7.5 s), and feedback (4 s). Inter-trial intervals were 1–8 s
(i.e., the ITI was jittered). Selection-phase responses were given with the right hand. Stimuli
were presented using Eprime presentation software (Psychology Software Tools Inc.,
Pittsburgh, PA) and displayed through magnet-compatible goggles (Resonance Technology,
Inc., Northridge CA).
Imaging Methods
Scanning was performed on a General Electric 4T LX NVi MRI scanner system equipped
with 41 mT/m gradients (General Electric, Waukesha, Wisconsin, USA). A quadrature
birdcage radio frequency head coil was used for transmit and receive. A high resolution T1-
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weighted image with 68 slices was acquired using a 3D fast SPGR pulse sequence (TR =
500 ms; TE = 20 ms; FOV = 24 cm; image matrix = 256 × 256; voxel size = 1.67 mm3) and
used for coregistration with the functional data. This structural image was aligned in a near
axial plane defined by the anterior and posterior commissures. Whole brain functional
images were acquired using an Echo Planar Imaging pulse sequence sensitive to blood
oxygenation level dependent contrast (TR, 1500 ms; TE, 31 ms; FOV, 24 cm; image matrix,
64 × 64; α= 62°; voxel size = 53.4375 mm3; 34 axial slices). Functional images were
aligned similarly to the T1-weighted structural image. A semi-automated high-order
shimming program ensured global field homogeneity.
The primary neuroimaging analysis was to evaluate voxels that revealed significant 2
(Group: MDD, nondepressed) X 2 (Time: Time 1, Time 2) interactions on contrasts of
interest. Activation values were uncorrected and combined with a cluster extent threshold of
eight uninterpolated voxels (supplemental materials provide a fuller description of these
analyses). For the selection and anticipation phases, monetary and control trials were
compared; for the feedback phase, win and loss feedback trials were compared separately to
control feedback trials. Because voxels corresponding to significant interactions may reflect
increased, decreased, or unchanged signal intensity in the MDD group relative to change in
the nondepressed group, whole-brain analyses were followed by two-tailed within-groups t-
tests (α=.05) of changes in signal intensity in voxels identified by the interaction test
described above. In this manner, statistical tests of fMRI changes due to psychotherapy were
restricted to voxels with significant interaction effects. This approach allows for a reduction
in the number of post-hoc statistical tests performed. Activation localizations were based on
Harvard-Oxford cortical and subcortical structural probabilistic atlases as implemented in
FSLView v3.0.
Results
Between-groups tests of Time 1 data have been reported previously (25). Here, we focus on
the critical Group X Time interaction effects.
Symptom Profiles and Psychotherapy Outcomes
Table 1 illustrates symptom profiles of participants at both timepoints. Group X Time tests
yielded significant interaction effects in depressive symptoms measured by both the HAM-D
(57) and the BDI (58), p’s<.0001, reflecting significant declines in both measures in the
MDD group, p’s<.0001. Two measures of symptoms of anhedonia, the Jackson Appetitive
Motivation Scale (59) and the Behavioral Activation / Behavioral Inhibition Scale (60), did
not show significant interactions.
Within the MDD group, HAM-D scores changed from 23.8 (SD=2.3) at Time 1 to 8.7
(SD=9.4) at Time 2 (p<.003). 75% (9/12) of participants were responders, defined as Time 2
HAM-D scores of six or below, and 83% (10/12) of participants were partial responders,
defined as Time 2 HAM-D scores of 10 or below.
Wheel of Fortune Outcome
Figure 2 depicts in-scanner WoF behavioral outcomes. All Group X Trial Type X Time
interactions were not significant, p’s > .10 (supplemental materials provide a fuller
description of these analyses).
Wheel of Fortune Imaging Data
Selection Phase—The top of Figure 3 depicts voxels with significant 2 (Group:
Depressed, Nondepressed) X 2 (Time: Time 1, Time 2) interaction effects on the money vs.
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control contrast during reward selection. Table 2 denotes all clusters showing significant
interactions, as well at the results of paired t-tests on signal intensity differences between
timepoints in the MDD group in clusters with significant interaction effects. Areas that
showed increased activation in the MDD group after psychotherapy included the
paracingulate gyrus (marginally significant at p=.06), the left putamen, the right
supramarginal gyrus, and the left posterior temporal fusiform cortex. Areas that showed
decreased activation in the MDD group, relative to baseline MDD scans, included the left
amygdala, the left superior frontal gyrus, the left superior lateral occipital cortex, the left
occipital pole, the left postcentral gyrus, the left precentral gyrus, the right supramarginal
gyrus, and the right inferior temporal gyrus.
Anticipation Phase—The bottom of Figure 3 depicts voxels with significant 2 (Group:
Depressed, Nondepressed) X 2 (Time: Time 1, Time 2) interaction effects on money vs.
control contrasts during reward anticipation. Table 3 denotes clusters showing significant
Group X Time interactions, as well at the results of paired t-tests on signal intensity
differences between timepoints in the MDD group in clusters with significant interaction
effects. Areas that showed increased activation in the MDD group after psychotherapy
included the left caudate, the anterior cingulate gyrus, the left middle and superior frontal
gyri, the left lingual gyrus, the left lateral and superior-lateral occipital cortex, the left
posterior parahippocampal gyrus, the right insular cortex, right precuneus, right subcallosal
cortex, right posterior temporal fusiform cortex, and bilateral precentral gyrus and temporal
poles. Areas that showed decreased activation in the MDD group after psychotherapy
included only the anterior inferior temporal gyrus.
Feedback Phase—Data from win and non-win trials were analyzed separately. Figure 4
depicts voxels with significant 2 (Group: Depressed, Nondepressed) X 2 (Time: Time 1,
Time 2) interactions for win vs. control (top) and non-win vs. control (bottom) contrasts.
Table 4 denotes clusters showing significant Group X Time interactions for these contrasts,
as well at the results of paired t-tests on signal intensity differences between timepoints in
the MDD group in clusters with significant interaction effects.
Areas that showed increased activation in the MDD group after psychotherapy during win
feedback included the left planum temporale, right superior lateral occipital cortex, and right
posterior temporal fusiform cortex. Areas that showed decreased activation after
psychotherapy included the left posterior cingulate, left caudate, left postcentral gyrus, and
left paracingulate gyrus. During non-win feedback, psychotherapy resulted in increased
activation in left lingual gyrus, left angular gyrus, left anterior superior temporal gyrus, left
orbital frontal cortex, left posterior superior temporal gyrus, and right planum temporale,
right posterior superior temporal gyrus, and right temporal pole. During non-win feedback,
psychotherapy resulted in decreased activation in left putamen, left superior lateral occipital
cortex, left precentral gyrus, and left anterior supramarginal gyrus in the MDD group.
Discussion
The goal of the present study was to elucidate BATD-related changes in brain function
during reward processing in MDD. Given animal evidence indicating that a potential final
common pathway of antidepressant treatments may be up-regulation of mesolimbic systems
(61), and because of linkages between mesolimbic functioning and reward anticipation (49,
62), primary hypotheses concerned BATD-related changes in the striatum during reward
anticipation.
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Analyses of selection data revealed a number of prefrontal regions with differential group
responses over time, including the paracingulate gyrus, bilateral orbital cortex bilateral
frontal pole, bilateral inferior frontal gyri, as well as limbic and occipital regions. Analyses
of the effects of BATD in the MDD group revealed significant increases in functioning of
the right paracingulate gyrus, the right posterior superior temporal gyrus, and portions of the
left supramarginal gyrus. Increased activation in the right paracingulate gyrus, though only
marginally significant, is particularly noteworthy, given that this region has been shown to
predict treatment response in an array of functional and metabolic imaging paradigms (e.g.,
2, 63, 64), though we note that this effect was a trend and should thus be interpreted with
caution. Areas showing decreased activation after BATD included the right amygdala, a
finding that was unexpected and bears replication. In a recent study using a modification of
the WOF task, Smith and colleagues (65) reported that selection of relatively larger rewards
activated the amygdala more strongly. Thus, in the present context, BATD treatment may
have decreased perceived reward magnitudes. Alternatively, at baseline there may have been
a mildly aversive quality to choosing a response for MDD participants due to the
indecisiveness that defines the disorder (66), and BATD treatment may have diminished this
aversive response. Other areas with decreased activation included the right superior frontal
gyrus, right occipital cortex, right precentral gyrus, right precentral gyrus, left supramarginal
gyrus, and left inferior temporal gyrus.
Reward Anticipation
Analyses of reward anticipation revealed differential group activation changes in the left
caudate nucleus, as well as a number of prefrontal regions, including the left cingulate gyrus,
left frontal gyrus, and right insula. In line with predictions, analyses of change within the
MDD group alone revealed that BATD produced significant increased activation in all these
regions, including the left caudate nucleus (i.e., the dorsal striatum). These findings
represent the first report of BATD-related increases in striatal activity during reward
anticipation in MDD. A number of other areas demonstrated increased activity after BATD,
including clusters in the left lingual gyrus, left occipital cortex, left parahippocampal gyrus,
and right temporal cortex. No clusters showed decreased activation after BATD relative to
changes in nondepressed group activations.
BATD-related increased striatal activity during reward anticipation is consistent with
preclinical and clinical models of MDD and anhedonia that implicate mesolimbic
dysregulation in the pathophysiology of MDD (67–71) and is consistent with the
conceptualization that the mechanisms of action of a range of antidepressant interventions is
improved mesolimbic functioning (61, 72–77).
Reward feedback
A number of frontal and limbic regions showed decreased activation after BATD, including
the right caudate nucleus and a large cluster in the left paracingulate gyrus. The decrease in
right caudate activation after BATD treatment in the MDD group was surprising and bears
replication. Caudate activation has been linked to learning cue-outcome contingencies (78,
79), particularly when potential gains require a motor response (80, 81). In the current study,
though wins were probabilistically determined, they were not directly contingent on
behavioral performance (e.g., reaction time or accuracy). Given that MDD is characterized
by decreased estimation of contingencies between behaviors and outcomes (i.e., decreased
positivity bias) (82), symptom remission may have normalized cue-outcome contingency
estimations and thus caudate activation – this feature of the WoF may account for the
apparent contradiction between the finding of decreased right caudate activation after BATD
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and other reports of reduced caudate activation in MDD (83, 84), particularly given that
groups did not differ at time 1 scans (23).
In contrast, analyses of non-win feedback revealed BATD-related increased activation in the
right lateral OFG. We interpret this finding to reflect the role of the OFC in modulating the
affective evaluation of rewards, expectation, motivation, decision-making and goal-directed
behavior (85–87), and, more specifically, to process violations of affective feedback
expectancies (88). In other words, it may be the case that, at pre-treatment, individuals with
MDD expected not to win positive outcomes; however, BATD may have induced a change
in this expectancy, such that not winning actually violated their expectancies to relatively a
greater degree, prompting greater OFC activation relative to their pre-treatment scans.
Limitations and Conclusions
The finding of increased striatal activation during reward anticipation after BATD was
localized to the dorsal striatum (i.e., caudate), rather then ventral striatum (i.e., nucleus
accumbens). The nucleus accumbens is thought to mediate internal representations of
predicted reward (79), whereas the caudate mediates linking rewards to behavior, reward-
related decision-making, and encoding motivational feedback (89–92). The localization of
activation to the caudate during reward anticipation may have been due to the WoF task: in
contrast to other tasks used to assess reward anticipation (21, 93), the WoF requires
behavioral responses during all phases. This cognitive component may have prompted
dorsal, rather than ventral, striatal responses (94).
The paracingulate cortex was reactive to BATD during two phases of reward responding
(i.e. selection and win feedback). The localization of the paracingulate cortex across these
three analyses (center of activations: +2, +52, −2, −4, 44, −8, and −2, 28, −10) overlaps the
subgenual cingulate cortex (Brodmann’s area 25). Subgenual cingulate metabolism has been
shown to predict response to a range of antidepressant interventions (both pharmacologic
and psychotherapy) (2, 3, 26, 95), and subgenual cingulate reactivity to emotional stimuli
has been implicated as a predictor of response to cognitive behavioral treatment (CBT) in
MDD using fMRI (37). This is in contrast to activation of medial aspects of the prefrontal
cortex, which has been shown to predict response to sleep deprivation (43), and to activity of
the rostral ACC (approximately Brodmann areas 24 and 32), which has been shown to
predict response to psychotropic medication in non-psychotic depression using
electromagnetic tomography (46, 96). More broadly, the present study adds to the growing
body of literature linking subregions of the anterior cingulate not only to the
pathophysiology of MDD, but to symptom remission in a variety of contexts.
We note that the present investigation did not include placebo or wait-list control groups,
and thus it is unknown whether functional brain changes in the MDD group were due to the
BATD intervention or to other variables, such as spontaneous improvement of symptoms
over time. Additionally, many brain regions reactive to psychotherapy were clearly outside
of reward structures. In this initial study, post-hoc tests of the effects of BATD in the MDD
group were not corrected for multiple comparisons, and thus findings regarding the effects
of BATD warrant replication. We also note that the three types of reward trials (i.e., equal,
moderate, and high risk) were combined, and activation magnitudes of certain brain regions,
such as the medial prefrontal cortex and the striatum, are known to vary parametrically with
reward magnitudes (97, 98). Finally, the relatively broader age range of the MDD group is
an additional limitation of this study.
Though this preliminary investigation evaluated a relatively small number of patients,
findings suggests that BATD results in recovery of function in brain regions related to
processing rewards. By utilizing a paradigm that allowed for an assessment of the different
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phases of responses to rewards, we were able to evaluate the effects of BATD on reward
selection, reward anticipation, and reward feedback. Imaging data revealed that BATD
normalized functioning in hypothesized areas, including the paracingulate cortex during
reward selection, the striatum during reward anticipation, and the orbital frontal cortex
during reward feedback. We conclude that functional changes within the reward network
may be a valuable biomarker of the effects of antidepressant treatments in MDD.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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The Wheel of Fortune task; (a) The four different wheel types; (b) The timing of three task
processes, i.e., reward selection, reward anticipation, and reward feedback.
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Top Left: Percentage of high risk selections (i.e., smaller pie slices) for the 10/90 and 30/70
conditions for both diagnostic groups at both timepoints. Top Right. Average confidence
ratings (range = 1 to 6) for both diagnostic groups at both timepoints. Note that the unequal
wheels are subdivided based on selection selections on a trial-by-trial basis (i.e., “risky” or
“safe” selections). Bottom Left: Ratings of feedback valence for win trials for both
diagnostic groups at both timepoints. On win trails, the range and direction of the ratings
were 1 = Neutral, 6 = Very Happy, whereas on no-win trials, the range and direction of the
ratings were 1 = Very Sad, 6 = Neutral. Bottom Right: Ratings of feedback valence for
non-win trials for both diagnostic groups at both timepoints. On win trails, the range and
direction of the ratings were 1 = Neutral, 6 = Very Happy, whereas on no-win trials, the
range and direction of the ratings were 1 = Very Sad, 6 = Neutral.
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Reward selection (top) and anticipation (bottom) fMRI results (money vs. control).
Activation images denote voxels with significant Group (Depressed, Nondepressed) X Time
(Time 1, Time 2) interactions. Neurological convention (right on right) is used and
coordinates are in MNI space. Signal intensity is T statistic units.
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Reward feedback fMRI results for win (top) and non-win (bottom) trials, relative to control
feedback. Activation images denote voxels with significant Group (Depressed,
Nondepressed) X Time (Time 1, Time 2) interactions. Neurological convention (right on
right) is used and coordinates are in MNI space. Signal intensity is T statistic units.
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